Pharmaceutical industry veteran Ernest Sabo plans to retire from Lannett Co. next year. The generic pharmaceutical company said late Monday that Sabo, vice president of regulatory affairs and chief compliance officer, is slated to retire effective Jan. 2, 2015.
Teva Canada Ltd. has released a generic version of Pfizer Inc.’s arthritis pain drug Celebrex (celecoxib). Teva said Monday that its generic celecoxib product, approved by Health Canada, is available now in pharmacies across Canada.
Cosmetics and beauty care giant Revlon Inc. has relaunched its brand with a global tagline, its first in more than a decade.
Patrick Lockwood-Taylor, vice president of personal health care for North America and digestive wellness design at Procter & Gamble Co., has been elected as chairman of the Consumer Healthcare Products Association (CHPA).
Galderma Laboratories has unveiled a new look for its Cetaphil RestoraDerm line of eczema-soothing products.
Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create one of the top-10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015.
The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as the agency seeks more bioequivalence information.
Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter & Gamble Co. The companies said Thursday that the deal, encompassing roughly $6.
Information and imaging technology giant Xerox is making an investment in telehealth provider HealthSpot Inc.
Kirby Lester reported a spike in sales of its KL1 and KL1Plus tablet counters in October following the Drug Enforcement Agency’s reclassification of hydrocodone combination products to Schedule II. Kirby Lester KL1 (left) and KL1Plus tablet counters.
Aaron Loutsch has been promoted to senior vice president and chief technology officer (CTO).
Eli Lilly and Co. has released Trulicity, a once-weekly treatment for type 2 diabetes, to U.S. pharmacies. Lilly said Monday that Trulicity (dulaglutide) comes in a single-dose pen, in 0.75 mg and 1.5 mg doses, and doesn’t require patients to mix, measure, or handle the needle.
Jolen Inc. has rolled out a new look for its Jolen Creme Bleach hair formula. The company said Monday that Jolen Creme Bleach retains its iconic logo and package color but sports a new package design to freshen up the brand’s look.
The findings of a national consumer survey on immunizations has led Rite Aid Corp. to launch Vaccine Central, a new online platform to raise awareness about vaccines and promote vaccinations. A key resource of the new Vaccine Central site is an immunization assessment tool.
Specialty pharmacy operators can expect to see escalating competition from retail pharmacy chains, which are rapidly expanding their specialty drug services, according to a study from Healthcare Research & Analytics (HRA).
Sara Rubin has joined the National Association of Chain Drug Stores as manager of pharmacy care. NACDS said Monday that Rubin will be responsible for supporting the development and implementation of the association’s pharmacy care initiatives.
